Logo 1 Logo 2

Clinical Trial Details

Trial ID: L5171
Source ID: NCT00859079
Associated Drug: Glp-1
Title: Efficacy of GLP-1 Infusion in Comparison to an Insulin Infusion Protocol to Reach Normoglycemia Type 2 Diabetic Patients
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus Type 2|Hyperglycemia
Interventions: DRUG: GLP-1|DRUG: Human regular insulin intravenously
Outcome Measures: Primary: time to reach a plasma glucose below 115 mg/dl, 0,30,60,120,150,180,210,240,270,300,330,360,390,420,450,480,510 min | Secondary: plasma glucose after 2 and 4 hours as well as maximum glycemia, 0,30,60,120,150,180,210,240,270,300,330,360,390,420,450,480,510 min|number of hypoglycaemic episodes, 0,30,60,120,150,180,210,240,270,300,330,360,390,420,450,480,510 min
Sponsor/Collaborators: Sponsor: Medical University of Graz
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 8
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2006-06
Completion Date: 2007-01
Results First Posted:
Last Update Posted: 2009-03-10
Locations: Medical University of Graz, Department for Internal Medicine, Graz, 8036, Austria
URL: https://clinicaltrials.gov/show/NCT00859079